Garofalo Health Care SpA (MIL:GHC) EBIT: €42.1 Mil (TTM As of Mar. 2026)


MIL:GHC Garofalo Health Care SpA MIL:GHC
86 GF Score
Price €5.26
GF Value €6.06
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Garofalo Health Care SpA EBIT?

Garofalo Health Care SpA MIL:GHC +0.77% 86 EBIT is €42.1 Mil as of Mar. 2026. GuruFocus rates MIL:GHC with a GF Score™ of 86/100 and a GF Value™ of €6.06 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Garofalo Health Care SpA's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €15.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €42.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Garofalo Health Care SpA's annualized ROC % for the quarter that ended in Mar. 2026 was 5.90%. Garofalo Health Care SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 19.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Garofalo Health Care SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.16%.


Garofalo Health Care SpA  (MIL:GHC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Garofalo Health Care SpA's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=64.544 * ( 1 - 31.38% )/( (725.864 + 775.123)/ 2 )
=44.2900928/750.4935
=5.90 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=859.819 - 103.524 - ( 30.431 - max(0, 136.581 - 167.559+30.431))
=725.864

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=897.482 - 99.424 - ( 27.325 - max(0, 154.591 - 177.526+27.325))
=775.123

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Garofalo Health Care SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=60.512/( ( (301.372 + max(0.547, 0)) + (311.363 + max(-5.959, 0)) )/ 2 )
=60.512/( ( 301.919 + 311.363 )/ 2 )
=60.512/306.641
=19.73 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(117.745 + 6.221 + 7.335) - (103.524 + 0 + 27.23)
=0.547

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(128.176 + 6.248 + 6.329) - (99.424 + 0 + 47.288)
=-5.959

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Garofalo Health Care SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=42.134/683.524
=6.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Garofalo Health Care SpA EBIT Related Terms


Garofalo Health Care SpA EBIT Historical Data

* Premium members only.

The historical data trend for Garofalo Health Care SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Garofalo Health Care SpA EBIT Chart

Garofalo Health Care SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.20 31.58 39.23 44.61 44.80

Garofalo Health Care SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.80 15.76 8.26 2.99 15.13

MIL:GHC vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Garofalo Health Care SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Garofalo Health Care SpA EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Garofalo Health Care SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Garofalo Health Care SpA's EV-to-EBIT falls into.


MIL:GHC
86GF Score
Garofalo Health Care SpA MIL:GHC
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Garofalo Health Care SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €42.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €42.1 Mil mean?
Garofalo Health Care SpA (MIL:GHC) has a EBIT of €42.1 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Garofalo Health Care SpA.
Is Garofalo Health Care SpA's EBIT too high?
Garofalo Health Care SpA's current EBIT is €42.1 Mil. Overall, Garofalo Health Care SpA has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Garofalo Health Care SpA's EBIT compare to HCA and THC?
Garofalo Health Care SpA's EBIT of €42.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Garofalo Health Care SpA. Garofalo Health Care SpA's current EBIT is €42.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garofalo Health Care SpA stock overvalued right now?
Based on GuruFocus' analysis, Garofalo Health Care SpA (MIL:GHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.06, compared to a current price of €5.26 — trading 13.2% below its estimated fair value. The current EBIT is €42.1 Mil. Garofalo Health Care SpA's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Garofalo Health Care SpA (MIL:GHC), the current EBIT is €42.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Garofalo Health Care SpA (MIL:GHC) Overvalued in 2026?

Based on GuruFocus' analysis, Garofalo Health Care SpA stock appears to be undervalued. The current stock price of €5.26 is trading 13.2% below its estimated GF Value™ of €6.06. GuruFocus considers Garofalo Health Care SpA to be Modestly Undervalued.

Key valuation signals for MIL:GHC:

  • EBIT: €42.1 Mil
  • GF Value™: €6.06 vs. price of €5.26 (13.2% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the MIL:GHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Garofalo Health Care SpA Business Description

Address Piazzale Belle Arti, 6, Rome, ITA, 00196
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
86GF Score

Get the complete analysis for MIL:GHC

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.26
Price
€6.06
GF Value